___

• Valls-Sole J. Assessment of excitability in brainstem circuits mediating the blink reflex and the startle reaction. Clin Neurophysiol. 2012; 123(1):13-20.
• Preston DC, Shapuo BE. Blink Reflex. In: Electromyography & Disorders Clinical-Electrophysiologic Correlations, 2nd eds. United States: Elsevier. 2005: 59-65.
• Kimura J. Electrodiagnosis in Diseases of Muscle and Nerve: Principles and Practice, 3rd eds. New York: Oxford. 2001: 409–38.
• Sahin S, Yaman M, Mungan SO, et al. What happens in the other eye? Blink reflex alterations in contralateral side after facial palsy. J Clin Neurophysiol. 2009;26(6): 454-7.
• Liao MF, Lee M, Hsieh MJ, et al. Evaluation of the pathophysiology of classical trigeminal neuralgia by blink reflex study and current perception threshold testing. J Headache Pain 2010;11(3):241-6.
• Ellrich J, Hopf HC. The R3 component of the blink reflex: normative data and application in spinal lesions. Electroencephalogr Clin Neurophysiol. 1996;101(4): 349-54.
• Leon L, Casanova-Molla J, Lauria G, et al. The somatosensory blink reflex in upper and lower brainstem lesions. Muscle Nerve 2011; 43(2):196-202.
• Diabetes Prevention Program Research Group. The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: an intent-to-treat analysis of the DPP/DPPOS. Diabetes Care 2012; 35(4): 723-30.
• Moutzouri E, Tsimihodimos V, Rizos E, et al. Prediabetes: to treat or not to treat? Eur J Pharmacol 2011; 672(1-3): 9-19.
• Tabak AG, Herder C, Rathmann W, et al. Prediabetes: a high- risk state for diabetes development. Lancet 2012; 379(9833): 2279-90.
• The Italian General Practitioner Study Group: Chronic symmetric symptomatic polyneuropathy in the elderly: a field screening investigation in two Italian regions. I. Prevalence and general characteristics of the sample. Neurology 1995; 45(10): 1832–6.
• Gregg EW, Sorlie P, Paulose-Ram R, et al. Prevalence of lower-extremity disease in the US adult population 40 years of age with and without diabetes: 1999–2000 National Health and Nutrition Examination Survey. Diabetes Care 2004; 27(7): 1591–7.
• Novella SP, Inzucchi SE, Goldstein JM. The frequency of undiagnosed diabetes and impaired glucose tolerance in patients with idiopathic sensory neuropathy. Muscle Nerve 2001; 24(9): 1229–31.
• Singleton JR, Smith AG, Bromberg MB. Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy. Diabetes Care 2001; 24(8): 1448–53.
• Sumner C, Seth S, Griffin J, et al. The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology 2003; 60(1): 108–11.
• Soriguer F, Goday A, Bosch-Comas A, et al. Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Diabetes Study. Diabetologia 2012; 55(1): 88-93.
• Smith AG, Singleton JR. Impaired glucose tolerance and neuropathy. Neurologist 2008; 14(1): 23-9.
• Dyck PJ, Dyck PJ, Klein CJ, et al. Does impaired glucose metabolism cause polyneuropathy? Review of previous studies and design of a prospective controlled population- based study. Muscle Nerve 2007; 36(4): 536–41.
• Smith AG, Ramachandran P, Tripp C, et al. Epidermal nerve innervations in impaired glucose tolerance and diabetes- associated neuropathy. Neurology 2001; 57(9): 1701–4.
• ADA Guidelines - http://www.diabetes.org. 2012.
• Zorba OU, Kirbaş S, Uzun H, et al. Is There a Relation between Reticular Formation and Storage Symptoms in Men. LUTS: Lower Urinary Tract Symptoms 2014; 6: 46-51.
• Kazem SS, Behzad D. Role of blink reflex in diagnosis of subclinical cranial neuropathy in diabetic mellitus type II. Am J Phys Med Rehabil 2006; 85(5): 449-52.
• Nazliel B, Yetkin I, Irkeç C, et al. Blink reflex abnormalities in diabetes mellitus. Diabetes Metab Res Rev 2001; 17(5): 396–400.
• Al-Azzawi LM, Mirza K, Kummoona R. The usefulness of the blink reflex in the early diagnosis of cranial nerve neuropathy associated with diabetes mellitus. Electromyogr Clin Neurophysiol 2004; 44(6): 323–7.
• Trujillo-Hernández B, Huerta M, Pérez-Vargas D, et al. Blink reflex alterations in recently diagnosed diabetic patients. J Clin Neurosci 2003; 10(3): 306-9.
• de Vegt F, Dekker JM, Jager A, et al. Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study. JAMA 2001; 285(16): 2109-13.
• Greene DA, Stevens MJ, Feldman EL. The sorbitol-osmotic and sorbitol-redox hypothesis. In: LeRoith D, Taylor S, Olefsky JM, editors. Diabetes mellitus: a fundamental and clinical text, eds. Philadelphia’Lipincott: Williams-Wilkins. 1996.
• Ziegler D, Rathmann W, Dickhaus T, et al. KORA Study Group. Neuropathic pain in diabetes, prediabetes and normal glucose tolerance: the MONICA/KORA Augsburg Surveys S2 and S3. Pain Med 2009; 10(2): 393-400.
• Hsu WC, Yen AM, Liou HH, et al. Prevalence and risk factors of somatic and autonomic neuropathy in prediabetic and diabetic patients. Neuroepidemiology 2009; 33(4): 344-9.
• Papanas N, Vinik AI, Ziegler D. Neuropathy in prediabetes: does the clock start ticking early? Nat Rev Endocrinol 2011; 7(11): 682-90.
• Divisova S, Vlckova E, Hnojcikova M, et al. Prediabetes/early predominantly involves sensory small fibres. J Peripher Nerv Syst 2012; 17(3): 341-50. neuropathy
• Vincent AM, Russell JW, Low P, et al. Oxidative stress in the pathogenesis of diabetic neuropathy. Endocr Rev 2004; 25(4): 612–28.
• Obrosova IG. Increased sorbitol pathway activity generates oxidative stress in tissue sites for diabetic complications. Antioxid Redox Signal 2005; 7(11-12): 1543–52.
• Vincent AM, Callaghan BC, Smith AL, et al. Diabetic neuropathy: cellular mechanisms as therapeutic targets. Nat Rev Neurol 2011; 7(10): 573–83.
• Duran-Jimenez B, Dobler D, Moffatt S, et al. Advanced glycation end products in extracellular matrix proteins contribute to the failure of sensory nerve regeneration in diabetes. Diabetes 2009; 58(12): 2893–903.
• Vincent AM, Perrone L, Sullivan KA, et al. Receptor for advanced glycation end products activation injures primary sensory neurons via oxidative stress. Endocrinology 2007; 148(2): 548–58.
• Wiggin TD, Sullivan KA, Pop-Busui R, et al. Elevated triglycerides correlate with progression of diabetic neuropathy. Diabetes 2009; 58(7):1634–40.
• Vincent AM, Hayes JM, McLean LL, et al. Dyslipidemia- induced neuropathy in mice: the role of oxLDL/LOX-1. Diabetes 2009; 58(10): 2376–85.
• McCall KD, Holliday D, Dickerson E, et al. Phenylmethimazole blocks palmitate-mediated induction of infl ammatory cytokine pathways in 3T3L1 adipocytes and RAW 264.7 macrophages. J Endocrinol 2010; 207(3): 343–53.
• Gordon Smith A, Robinson Singleton J. Idiopathic neuropathy, prediabetes and the metabolic syndrome. J Neurol Sci 2006; 242(1-2): 9-14.